Status:
WITHDRAWN
Antibiotic Prophylaxis in Children With Pyelonephritis
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Canadian Urological Association
Conditions:
Pyelonephritis
Eligibility:
All Genders
Up to 12 years
Phase:
PHASE3
Brief Summary
Children who present with pyelonephritis undergo many investigations, and long term care to prevent renal damage. The focus is primarily on preventing renal failure however along the way and particula...
Eligibility Criteria
Inclusion
- Children 0 to 12 years of age presenting with first episode of acute pyelonephritis in the absence of vesicoureteral reflux.
- Acute pyelonephritis defined as presence of fever, a positive urine culture (growth of a single urinary tract pathogen at =10(8) CFU/ml for catheterization specimens and =10(4) CFU/ml for clean catch specimens), and a positive DMSA scan (a discreet defect or generalized decrease in activity).
Exclusion
- Neurogenic bladder
- anatomic congenital anomaly
- allergy to all prophylactic antibiotics
- children whose parents do not wish to participate
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00752375
Start Date
February 1 2009
End Date
December 1 2014
Last Update
January 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stollery Children's Hospital
Edmonton, Alberta, Canada, T6G 2B7